Treace Medical Concepts Inc
NASDAQ:TMCI

Watchlist Manager
Treace Medical Concepts Inc Logo
Treace Medical Concepts Inc
NASDAQ:TMCI
Watchlist
Price: 5.04 USD -5.44%
Updated: May 24, 2024
TMCI
/
Income Statement
/
Cost of Revenue

Treace Medical Concepts Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Treace Medical Concepts Inc
Cost of Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Treace Medical Concepts Inc
NASDAQ:TMCI
Cost of Revenue
-$37.3m
CAGR 3-Years
-41%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Cost of Revenue
-$11.6B
CAGR 3-Years
-7%
CAGR 5-Years
-5%
CAGR 10-Years
-11%
Boston Scientific Corp
NYSE:BSX
Cost of Revenue
-$4.5B
CAGR 3-Years
-8%
CAGR 5-Years
-9%
CAGR 10-Years
-7%
Stryker Corp
NYSE:SYK
Cost of Revenue
-$7.5B
CAGR 3-Years
-11%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
Abbott Laboratories
NYSE:ABT
Cost of Revenue
-$18B
CAGR 3-Years
-4%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cost of Revenue
-$2.5B
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
-14%

See Also

What is Treace Medical Concepts Inc's Cost of Revenue?
Cost of Revenue
-37.3m USD

Based on the financial report for Mar 31, 2024, Treace Medical Concepts Inc's Cost of Revenue amounts to -37.3m USD.

What is Treace Medical Concepts Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-41%

Over the last year, the Cost of Revenue growth was -26%. The average annual Cost of Revenue growth rates for Treace Medical Concepts Inc have been -41% over the past three years .

ALPHA SPREAD
Join more than 140,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.